These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 35671859)
1. Ube2c-inhibition alleviated amyloid pathology and memory deficits in APP/PS1 mice model of AD. Li T; Su Q; Zhang Z; Zhang Y; Yang M; Wang Z; Guo J; Wang Z; Wu M; Cai H; Qi J Prog Neurobiol; 2022 Aug; 215():102298. PubMed ID: 35671859 [TBL] [Abstract][Full Text] [Related]
2. Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Luo R; Su LY; Li G; Yang J; Liu Q; Yang LX; Zhang DF; Zhou H; Xu M; Fan Y; Li J; Yao YG Autophagy; 2020 Jan; 16(1):52-69. PubMed ID: 30898012 [TBL] [Abstract][Full Text] [Related]
3. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease. Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249 [TBL] [Abstract][Full Text] [Related]
4. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease. McClean PL; Hölscher C Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293 [TBL] [Abstract][Full Text] [Related]
5. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease. Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067 [TBL] [Abstract][Full Text] [Related]
6. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease. Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318 [TBL] [Abstract][Full Text] [Related]
7. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769 [TBL] [Abstract][Full Text] [Related]
8. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner. Lecordier S; Pons V; Rivest S; ElAli A Front Immunol; 2021; 12():813536. PubMed ID: 35173711 [TBL] [Abstract][Full Text] [Related]
9. Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer's disease. Horibe S; Emoto T; Mizoguchi T; Tanaka T; Kawauchi S; Sasaki N; Yamashita T; Ikeda K; Emoto N; Hirata KI; Rikitake Y Glia; 2024 Jan; 72(1):51-68. PubMed ID: 37610154 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice. Rodriguez G; Eren M; Haupfear I; Viola KL; Cline EN; Miyata T; Klein WL; Vaughan DE; Dong H Psychopharmacology (Berl); 2023 Dec; 240(12):2641-2655. PubMed ID: 37700086 [TBL] [Abstract][Full Text] [Related]
11. Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice. Wang C; Gao WR; Yin J; Wang ZJ; Qi JS; Cai HY; Wu MN Behav Brain Res; 2021 Aug; 412():113400. PubMed ID: 34087256 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice. Li X; Zhang H; Yang L; Dong X; Han Y; Su Y; Li W; Li W Behav Brain Funct; 2023 Apr; 19(1):7. PubMed ID: 37055801 [TBL] [Abstract][Full Text] [Related]
13. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes. Jiang H; Niu F; Zheng Y; Xu Y Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684 [TBL] [Abstract][Full Text] [Related]
14. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice. Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332 [TBL] [Abstract][Full Text] [Related]
15. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Joshi G; Gan KA; Johnson DA; Johnson JA Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599 [TBL] [Abstract][Full Text] [Related]
16. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance. Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458 [TBL] [Abstract][Full Text] [Related]
17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
18. β‑asarone modulates Beclin‑1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease. Deng M; Huang L; Zhong X Mol Med Rep; 2020 May; 21(5):2095-2102. PubMed ID: 32186763 [TBL] [Abstract][Full Text] [Related]
19. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease. Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065 [TBL] [Abstract][Full Text] [Related]
20. Differential activation of the mTOR/autophagy pathway predicts cognitive performance in APP/PS1 mice. Vartak RS; Rodin A; Oddo S Neurobiol Aging; 2019 Nov; 83():105-113. PubMed ID: 31585361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]